Lozano Realty Team

Lozano Realty Team REALTORS® | Ovarian Cancer Survivor | Veteran | Animal rescue advocates | Proud supporter of our Military, Veterans, and 1st Responders.

When you work with Lozano Realty Team, you get 2 Full Service REALTORS®️for the price of 1!

🏡 CREDIT READY FOR HOMEOWNERSHIPYour dream home starts with a stronger financial foundation.Improve your mortgage readin...
09/10/2026

🏡 CREDIT READY FOR HOMEOWNERSHIP

Your dream home starts with a stronger financial foundation.

Improve your mortgage readiness by:

✓ Paying every bill on time
✓ Lowering credit-card balances
✓ Checking all three credit reports
✓ Disputing inaccurate information
✓ Avoiding unnecessary new credit
✓ Speaking with a qualified lender early

There is no overnight credit fix—but consistent steps can improve your loan options, interest rate, and monthly payment.

Start early. Stay consistent. Get mortgage-ready.

🏡 BACK ON THE MARKET + OPEN HOUSE THIS SATURDAY!📍 7457 Pondview Ln, Tivolo Park, Fort Worth🗓 Saturday | ⏰ 1:00–3:00 PM💲 ...
09/09/2026

🏡 BACK ON THE MARKET + OPEN HOUSE THIS SATURDAY!

📍 7457 Pondview Ln, Tivolo Park, Fort Worth
🗓 Saturday | ⏰ 1:00–3:00 PM
💲 $574,900
🛏️ 4 bedrooms | 🛁 3 bathrooms | 📐 3,284 sq. ft.

This beautiful home is back on the market through no fault of the home or seller. The previous buyer’s home did not sell, so their contingency fell through—giving another buyer a fresh opportunity!

If you’ve been waiting for the right home in Tivolo Park, come see it in person this Saturday. Message us for more details or to schedule a private showing.

LozanoRealtyTeam

🩵 DAY 9: WHY LONG-TERM FOLLOW-UP MATTERS WITH GCT 🩵One thing that makes Adult Granulosa Cell Tumor (AGCT) different from...
09/09/2026

🩵 DAY 9: WHY LONG-TERM FOLLOW-UP MATTERS WITH GCT 🩵

One thing that makes Adult Granulosa Cell Tumor (AGCT) different from many other ovarian cancers is how slowly it can grow.

Even after successful treatment, AGCT has the potential to recur many years—even decades—later. That doesn’t mean recurrence will happen, but it does mean follow-up shouldn’t simply stop after five years.

Monitoring may include:

🩵 Regular visits with your gynecologic oncologist
🩵 Blood tests such as Inhibin B and/or AMH when appropriate
🩵 Paying attention to new or persistent symptoms
🩵 Imaging when symptoms, exams, or tumor markers give a reason to investigate

For those of us diagnosed at an early stage, it can be tempting to think, “It’s gone, so I’m finished with this.” And hopefully, we are! But with GCT, long-term surveillance is part of staying informed—not living in fear.

The goal is simple: if something ever does change, we want the opportunity to find it as early as possible.

🩵 GCT may be slow-growing, but our follow-up needs to be long-lasting.

OvarianCancer RareCancer TealSeptember Day9

🩵 DAY 8: WHAT MAKES FOXL2 MUTATE? 🩵Yesterday I talked about the FOXL2 mutation found in about 95–97% of adult granulosa ...
09/08/2026

🩵 DAY 8: WHAT MAKES FOXL2 MUTATE? 🩵

Yesterday I talked about the FOXL2 mutation found in about 95–97% of adult granulosa cell tumors (AGCTs). But that raises an obvious question: What makes that gene mutate in the first place?

The answer may be frustrating: science still doesn’t know. The characteristic FOXL2 c.402C>G (p.C134W) mutation is a somatic mutation—an acquired DNA change in the tumor cells rather than something most patients were born with. Researchers believe it is a major driver of AGCT, but they have not identified a lifestyle, food, environmental exposure, hormone level, stressor, or other behavior that causes this specific mutation.

And here’s an important misconception I want to clear up:

🧬 After an AGCT is completely removed, the goal isn’t to keep FOXL2 from “mutating again.”

A recurrence generally isn’t thought to happen because a brand-new FOXL2 mutation suddenly develops in another normal cell. Studies comparing original tumors with later recurrences have found the same FOXL2 mutation preserved in recurrent tumor cells, supporting the idea that recurrence can arise from cancer cells from the original tumor that remained behind at a microscopic level and later began growing.

So what can we do to prevent it?

Unfortunately, there is currently no proven diet, supplement, medication or lifestyle change that can prevent the FOXL2 mutation or guarantee that AGCT won’t recur. Researchers are studying additional genetic changes associated with progression and recurrence, including TERT promoter alterations, but we still don’t have a proven way to stop recurrence before it happens.

What we can do is stay informed and continue long-term follow-up, because AGCT is known for its ability to recur years—even many years—after the original tumor is removed.

🩵 We didn’t cause the mutation. We currently can’t “unmutate” it. But understanding FOXL2 gives researchers an important target for figuring out how AGCT starts, survives and may someday be stopped more effectively.

More research. More answers. More tomorrows. 🩵

RareCancer TealSeptember Day8

🩵 DAY 7: GRANULOSA CELL TUMORS & FOXL2 🩵Today I’m highlighting the type of ovarian cancer that is especially personal to...
09/07/2026

🩵 DAY 7: GRANULOSA CELL TUMORS & FOXL2 🩵

Today I’m highlighting the type of ovarian cancer that is especially personal to me: Granulosa Cell Tumor (GCT).

GCT is a rare ovarian cancer that develops from granulosa cells, which help produce hormones such as estrogen.

So what causes it? We still don’t completely know. But researchers have discovered an important clue. 🧬

Approximately 95–97% of adult-type GCTs have a specific mutation in the FOXL2 gene (c.402C>G, p.C134W). This mutation is considered a molecular hallmark of adult-type GCT and is believed to play an important role in the cancer’s development.

Importantly, this mutation is usually acquired in the tumor cells—not inherited like BRCA mutations. Researchers still don’t know exactly why the FOXL2 mutation occurs or what additional changes cause GCT to develop.

GCT is biologically different from the more common ovarian cancers and can even recur many years after the original diagnosis—one reason long-term follow-up and more research are so important.

🩵 Rare doesn’t mean unimportant.

More awareness. More research. More answers. More tomorrows.

TealSeptember Day7

🩵 DAY 6: OVARIAN CANCER CAN HAPPEN AT ANY AGE 🩵Ovarian cancer is often thought of as a disease that only affects older w...
09/06/2026

🩵 DAY 6: OVARIAN CANCER CAN HAPPEN AT ANY AGE 🩵

Ovarian cancer is often thought of as a disease that only affects older women. While the risk of the most common types does increase with age, ovarian tumors can occur in younger women, too.

Different types tend to affect different age groups:

🩵 Epithelial ovarian cancers are most common in women over 50.

🩵 Germ cell tumors are more likely to occur in teens and younger women.

🩵 Granulosa cell tumors (GCTs) can occur at many ages. Adult-type GCTs are most often diagnosed around or after menopause, while the much rarer juvenile type usually occurs in children and younger women.

This is another reason ovarian cancer shouldn’t be treated as one single disease. Age alone cannot rule it out.

No matter your age, persistent changes in your body deserve attention. Know what’s normal for you, and don’t be afraid to advocate for yourself when something isn’t right. 🩵

Cancer doesn’t check your birth certificate. Awareness matters at every age.

TealSeptember Day6

🩵 DAY 5: KNOW THE RISK FACTORS 🩵There’s no single cause of ovarian cancer, and having a risk factor does not mean you’ll...
09/05/2026

🩵 DAY 5: KNOW THE RISK FACTORS 🩵

There’s no single cause of ovarian cancer, and having a risk factor does not mean you’ll develop it.

Some known risk factors include:
🩵 Increasing age
🩵 BRCA1/BRCA2 or Lynch syndrome mutations
🩵 Family or personal history of certain cancers
🩵 Endometriosis
🩵 Certain reproductive factors

But ovarian cancer can also occur without any obvious risk factors or family history.

🔬 A fascinating fact about Granulosa Cell Tumors (GCTs):

Approximately 95–97% of adult-type ovarian GCTs contain a specific mutation in the FOXL2 gene (c.402C>G, p.C134W).

Unlike inherited mutations such as BRCA, this FOXL2 mutation is generally found in the tumor itself and is not inherited. It has become an important molecular hallmark of adult-type GCT.

Rare ovarian cancers deserve awareness and research, too. 🩵

More awareness. More research. More tomorrows.

RareCancer TealSeptember Day5

If you are in need of lawn care before and/or while we sell your house, and/or if you need help moving to your next home...
09/05/2026

If you are in need of lawn care before and/or while we sell your house, and/or if you need help moving to your next home once your house is sold,
Call Sky at Sky is the Limit Moving and Lawn Care! He and his team will get the job done with outstanding service!

🩵 DAY 4: OVARIAN CANCER ISN’T JUST ONE DISEASE 🩵When we say “ovarian cancer,” it sounds like we’re talking about one typ...
09/05/2026

🩵 DAY 4: OVARIAN CANCER ISN’T JUST ONE DISEASE 🩵

When we say “ovarian cancer,” it sounds like we’re talking about one type of cancer. We’re not.

There are several different types, and they can behave very differently.

🔹 Epithelial ovarian cancer is by far the most common and includes high-grade serous carcinoma, the type most people are referring to when discussing ovarian cancer.

🔹 Germ cell tumors begin in the cells that produce eggs. They are rare and occur more often in younger women.

🔹 S*x cord-stromal tumors begin in the cells that support the o***y and produce hormones. These are also rare and include granulosa cell tumors (GCTs).

This distinction matters because different ovarian cancers can have different risk factors, treatments, recurrence patterns and follow-up needs.

As someone who had a granulosa cell tumor, this part of ovarian cancer awareness is especially important to me. Rare ovarian cancers deserve awareness and research, too. 🩵

Tomorrow, I’ll share more about granulosa cell tumors, because ovarian cancer awareness should include the rare types, too.

Different types. Different behaviors. One teal ribbon. 🩵

TealSeptember Day4

🩵 DAY 3: THERE IS NO ROUTINE SCREENING TEST FOR OVARIAN CANCER 🩵This is something I wish more women knew.We have mammogr...
09/04/2026

🩵 DAY 3: THERE IS NO ROUTINE SCREENING TEST FOR OVARIAN CANCER 🩵

This is something I wish more women knew.

We have mammograms to screen for breast cancer.
Colonoscopies to screen for colorectal cancer.
Pap and HPV tests to screen for cervical cancer.

But for women at average risk, there is currently no reliable routine screening test recommended for ovarian cancer.

And just to clear up a very common misconception:

🚫 A Pap smear does NOT screen for ovarian cancer.

Tests such as CA-125 blood tests and transvaginal ultrasounds can be useful when a doctor is investigating symptoms or monitoring certain patients, but they have not been shown to work well enough as routine screening tests for average-risk women without symptoms.

That’s why knowing the symptoms we talked about yesterday matters so much.

🩵 Pay attention to changes in your body.
🩵 Know your family history.
🩵 Don’t ignore persistent symptoms.
🩵 Speak up when something doesn’t feel right.

We need better screening. We need more research. And until then, awareness is one of the tools we DO have.

Share this with the women in your life. 🩵

Day3

Address

6238 Camp Bowie Boulevard
Fort Worth, TX
76116

Alerts

Be the first to know and let us send you an email when Lozano Realty Team posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Lozano Realty Team:

Shortcuts

Share

Category